What is the dispensing fee limitation for the EO for a listed drug product in one calendar month?

In this context, the correct limitation for dispensing fees for a listed drug product under the Exceptional Access Program (EO) is that a pharmacy may charge a maximum of two dispensing fees per calendar month. This is important for several reasons.

The Exceptional Access Program allows patients to access medications that are not covered under the standard Ontario Drug Benefit (ODB) formulary. The limitation on dispensing fees is designed to ensure that while patients can obtain necessary medications, the healthcare system remains sustainable and equitable. By capping the number of fees that can be charged in a month, it prevents excessive costs being passed onto the public system while still allowing pharmacies to be compensated for their services.

Understanding this limitation helps pharmacy professionals comprehend the broader implications of drug reimbursement policies and the significance of maintaining compliance with regulatory frameworks. It also emphasizes the importance of providing necessary medications while ensuring that the costs do not become prohibitive for the healthcare system.

The other options reflect a higher allowable number of dispensing fees, which does not align with the regulations set forth by the ODB concerning the dispensing fee limitation for listed drug products under the EO. This underscores the importance of staying updated with current legislation and policies regarding pharmacy practices, as they are integral to the functioning of the pharmaceutical care system.